Cargando…

Laterality of specific binding ratios on DAT-SPECT for differential diagnosis of degenerative parkinsonian syndromes

Motor symptoms of Parkinson’s disease (PD) occur unilaterally and progress with asymmetry, while progressive supranuclear palsy (PSP) and multiple system atrophy of the parkinsonism subtype (MSA-P) lack this tendency. We assessed the laterality of specific binding ratios (SBRs) on dopamine transport...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shigekiyo, Taro, Arawaka, Shigeki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7519659/ https://www.ncbi.nlm.nih.gov/pubmed/32978422 http://dx.doi.org/10.1038/s41598-020-72321-y

Ejemplares similares

Clinical utility of dopamine transporter single photon emission CT (DaT-SPECT) with ((123)I) ioflupane in diagnosis of parkinsonian syndromes
por: Bajaj, Nin, et al.
Publicado: (2013)

Correlations between cerebrospinal fluid homovanillic acid and dopamine transporter SPECT in degenerative parkinsonian syndromes
por: Goto, Ryoji, et al.
Publicado: (2023)

A diagnostic strategy for Parkinsonian syndromes using quantitative indices of DAT SPECT and MIBG scintigraphy: an investigation using the classification and regression tree analysis
por: Iwabuchi, Yu, et al.
Publicado: (2021)

Clinical Implications of Cardiac-MIBG SPECT in the Differentiation of Parkinsonian Syndromes
por: Shin, Dong Hoon, et al.
Publicado: (2006)

Application of texture analysis to DAT SPECT imaging: Relationship to clinical assessments
por: Rahmim, Arman, et al.
Publicado: (2016)

Negative DAT‐SPECT in Old Onset Parkinson's Disease: An Additional Pitfall?
por: Palermo, Giovanni, et al.
Publicado: (2022)

Meta-analysis of the literature on diagnostic accuracy of SPECT in parkinsonian syndromes
por: Vlaar, Annemarie MM, et al.
Publicado: (2007)

FDG PET in the differential diagnosis of degenerative parkinsonian disorders: usefulness of voxel-based analysis in clinical practice
por: Arnone, Annachiara, et al.
Publicado: (2022)

Neuromelanin or DaT‐SPECT: which is the better marker for discriminating advanced Parkinson's disease?
por: Okuzumi, A., et al.
Publicado: (2019)

The predictive value of transcranial duplex sonography for the clinical diagnosis in undiagnosed parkinsonian syndromes: comparison with SPECT scans
por: Vlaar, Annemarie MM, et al.
Publicado: (2008)

Utility of the combination of DAT SPECT and MIBG myocardial scintigraphy in differentiating dementia with Lewy bodies from Alzheimer’s disease
por: Shimizu, Soichiro, et al.
Publicado: (2015)

Dopamine transporter SPECT imaging in Parkinson’s disease and parkinsonian disorders
por: AKDEMİR, Ümit Özgür, et al.
Publicado: (2021)

The Combination of DAT-SPECT, Structural and Diffusion MRI Predicts Clinical Progression in Parkinson’s Disease
por: Lorio, Sara, et al.
Publicado: (2019)

Subacute Combined Degeneration of the Spinal Cord Caused by Autoimmune Gastritis
por: Ota, Kazuhiro, et al.
Publicado: (2020)

Multi-Atlas MRI-Based Striatum Segmentation for (123)I-FP-CIT SPECT (DAT-SPECT) Compared With the Bolt Method and SPECT-Atlas-Based Segmentation Method Toward the Accurate Diagnosis of Parkinson's Disease/Syndrome
por: Sohara, Koji, et al.
Publicado: (2021)

The utility of the combination of a SPECT study with [(123)I]-FP-CIT of dopamine transporters and [(123)I]-MIBG myocardial scintigraphy in differentiating Parkinson disease from other degenerative parkinsonian syndromes
por: Uyama, Naoto, et al.
Publicado: (2017)

Improved prediction of outcome in Parkinson's disease using radiomics analysis of longitudinal DAT SPECT images
por: Rahmim, Arman, et al.
Publicado: (2017)

Hoehn and Yahr Stage and Striatal Dat-SPECT Uptake Are Predictors of Parkinson’s Disease Motor Progression
por: Jackson, Holly, et al.
Publicado: (2021)

Brain MR Contribution to the Differential Diagnosis of Parkinsonian Syndromes: An Update
por: Rizzo, Giovanni, et al.
Publicado: (2016)

A Panel of Plasma Biomarkers for Differential Diagnosis of Parkinsonian Syndromes
por: Li, Qi, et al.
Publicado: (2022)

Impact of the size of the normal database on the performance of the specific binding ratio in dopamine transporter SPECT
por: Schmitz-Steinkrüger, Helen, et al.
Publicado: (2020)

Dopamine transporter single photon emission computed tomography (DaT-SPECT) use in the diagnosis and clinical management of parkinsonism: an 8-year retrospective study
por: Tsang, Kaki, et al.
Publicado: (2023)

Explainable AI to improve acceptance of convolutional neural networks for automatic classification of dopamine transporter SPECT in the diagnosis of clinically uncertain parkinsonian syndromes
por: Nazari, Mahmood, et al.
Publicado: (2021)

Diagnoses behind patients with hard-to-classify tremor and normal DaT-SPECT: a clinical follow up study
por: Menéndez-González, Manuel, et al.
Publicado: (2014)

Pre- and Postsynaptic Dopamine SPECT in Idiopathic Parkinsonian Diseases: A Follow-Up Study
por: Jakobson Mo, Susanna, et al.
Publicado: (2013)

No impact of attenuation and scatter correction on the interpretation of dopamine transporter SPECT in patients with clinically uncertain parkinsonian syndrome
por: Schiebler, Tassilo, et al.
Publicado: (2023)

Differential Diagnosis Tool for Parkinsonian Syndrome Using Multiple Structural Brain Measures
por: Ota, Miho, et al.
Publicado: (2013)

Magnetic resonance imaging modalities aid in the differential diagnosis of atypical parkinsonian syndromes
por: Tinaz, Sule
Publicado: (2023)

The association of DAT gene methylation with striatal DAT availability in healthy subjects
por: Pak, Kyoungjune, et al.
Publicado: (2021)

Prediction of Cognitive Decline in Parkinson’s Disease Using Clinical and DAT SPECT Imaging Features, and Hybrid Machine Learning Systems
por: Hosseinzadeh, Mahdi, et al.
Publicado: (2023)

The Parkinsonian Syndrome : Some Points in Diagnosis and Treatment
por: Critchley, Macdonald
Publicado: (1924)

Impact of the cerebrospinal fluid-mask algorithm on the diagnostic performance of (123)I-Ioflupane SPECT: an investigation of parkinsonian syndromes
por: Iwabuchi, Yu, et al.
Publicado: (2019)

Multi-Modal Synergistic 99mTc-TRODAT-1 SPECT and MRI for Evaluation of the Efficacy of Hyperbaric Oxygen Therapy in CO-Induced Delayed Parkinsonian and Non-Parkinsonian Syndromes
por: Yeh, Skye Hsin-Hsien, et al.
Publicado: (2022)

Test of DAT-DISP
Publicado: (1980)

Striatal DAT and extrastriatal SERT binding in early-stage Parkinson's disease and dementia with Lewy bodies, compared with healthy controls: An (123)I-FP-CIT SPECT study
por: Joling, Merijn, et al.
Publicado: (2019)

Neuron-specific enolase level is a useful biomarker for distinguishing amyotrophic lateral sclerosis from cervical spondylotic myelopathy
por: Tsukahara, Akihiro, et al.
Publicado: (2021)

SERT-to-DAT ratios in early Parkinson’s disease do not correlate with the development of dyskinesias
por: Suwijn, Sven R, et al.
Publicado: (2013)

Correction: The association of DAT gene methylation with striatal DAT availability in healthy subjects
por: Pak, Kyoungjune, et al.
Publicado: (2023)

Count-based method for specific binding ratio calculation in [I-123]FP-CIT SPECT analysis
por: Rahman, Mahmudur G. M., et al.
Publicado: (2018)

A Novel Automatic Approach for Calculation of the Specific Binding Ratio in [I-123]FP-CIT SPECT
por: Rahman, Mahmudur G. M., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_cks09j8mrqcu9q2j6vkiqrdeau